Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 22, 2022
Patent Application Number
17407774
Date Filed
August 20, 2021
Patent Citations
Patent Primary Examiner
Anti-FGFR3 antigen-binding proteins and antigen-binding binding fragments thereof are provided. Methods of inhibiting FGFR3 activity and methods of treating FGFR3-mediated diseases and disorders are also provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
